Determining the subjective and physiological effects of BZP combined with TFMPP in human males

Psychopharmacology

Volumn 214, Issue 3, 2011, Pages 761-768

  Lin, Joanne C ^a   Jan, Reem K ^a   Lee, HeeSeung ^a   Jensen, Maree Ann ^a   Kydd, Rob R ^a   Russell, Bruce R ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Benzylpiperazine (BZP); Human; Mood; Party pills; Trifluoromethylphenylpiperazine (TFMPP)

Indexed keywords

1 (3 TRIFLUOROMETHYLPHENYL)PIPERAZINE; BENZYLPIPERAZINE; DEXAMPHETAMINE; PIPERAZINE DERIVATIVE; PLACEBO; RECREATIONAL DRUG; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY TEMPERATURE MEASUREMENT; CHEMICAL ANALYSIS; CIGARETTE SMOKING; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DYSPHORIA; HEART RATE; HUMAN; MALE; PRIORITY JOURNAL; SELF CONCEPT; SYSTOLIC BLOOD PRESSURE;

ADOLESCENT; ADULT; AFFECT; ANALYSIS OF VARIANCE; BLOOD PRESSURE; BODY TEMPERATURE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; HEART RATE; HUMANS; MALE; NEW ZEALAND; PAIN MEASUREMENT; PHYSIOLOGICAL PHENOMENA; PIPERAZINES; PSYCHIATRIC STATUS RATING SCALES; STREET DRUGS; YOUNG ADULT;

EID: 79953665710     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-010-2081-7     Document Type: Article

References (42)

1. Antia U, Lee HS, Kydd RR, Tingle MD, Russell BR (2009a) Pharmacokinetics of 'party pill' drug N-benzylpiperazine (BZP) in healthy human participants. Forensic Sci Int 186:63-67
2. Antia U, Tingle MD, Russell BR (2009b) In vivo interactions between BZP and TFMPP (party pill drugs). NZ Med J 122:29-38
3. Antia U, Tingle MD, Russell BR (2009c) Metabolic interactions with piperazine-based 'party pill' drugs. J Pharm Pharmacol 61:877-882
4. Antia U, Tingle MD, Russell BR (2010) Validation of an LC-MS method for the detection and quantification of bzp and tfmpp and their hydroxylated metabolites in human plasma and its application to the pharmacokinetic study of TFMPP in Humans*. J Forensic Sci 55:1311-1318
5. Appel JB, Callahan PM (1989) Involvement of 5-HT receptor subtypes in the discriminative stimulus properties of mescaline. Eur J Pharmacol 159:41-46 (Pubitemid 19020812)
6. Auerbach SB, Rutter JJ, Juliano PJ (1991) Substituted piperazine and indole compounds increase extracellular serotonin in rat diencephalon as determined by in vivo microdialysis. Neuropharmacology 30:307-311
7. Baumann MH, Clark RD, Budzynski AG, Partilla JS, Blough BE, Rothman RB (2005) N-substituted piperazines abused by humans mimic the molecular mechanism of 3,4-methylenedioxymethamphetamine (MDMA, or 'Ecstasy'). Neuropsychopharmacology 30:550-560 (Pubitemid 40271157)
8. Bellis MA, Hughes K, Lowey H (2002) Healthy nightclubs and recreational substance use: from a harm minimisation to a healthy settings approach. Addict Behav 27:1025-1035 (Pubitemid 36158762)
9. Bushnell PJ, Gordon CJ (1987) Effects of d-amphetamine on behavioral and autonomic thermoregulation in mice. Pharmacol Biochem Behav 27:431-435 (Pubitemid 17107011)
10. Bye C, Munro-Faure AD, Peck AW, Young PA (1973) A Comparison of the effects of 1-benzylpiperazine and dexamphetamine on human performance tests. Eur J Clin Pharmacol 6:163-169
11. Campbell H, Cline W, Evans M, Lloyd J, Peck AW (1973) Comparison of the effects of dexamphetamine and 1-benzylpiperazine in former addicts. Eur J Clin Pharmacol 6:170-176
12. Chait LD, Johanson C-E (1988) Discriminative stimulus effects of caffeine and benzphetamine in amphetamine-trained volunteers. Psychopharmacology 96:302-308
13. Chait LD, Uhlenhuth EH, Johanson C-E (1985) The discriminative stimulus and subjective effects of d-amphetmine in humans. Psychopharmacology 86:307-312 (Pubitemid 15064956)
14. Christensen L (1993) Effects of eating behavior on mood: a review of literature. Int J Eat Disord 14:171-183
15. Cloëz-Tayarani I, Harel-Dupas C, Fillion G (1992) Inhibition of [3 H] gamma-aminobutyric acid release from guinea-pig hippocampal synaptosomes by serotonergic agents. Fundam Clin Pharmacol 6:333-341 (Pubitemid 23026784)
16. DEA (2010) Drug Enforcement Administration - Drugs and Chemicals of Concern: N-benzylpiperazine, http://www.deadiversion.usdoj.gov/drugs-concern/ bzp-tmp/bzp-tmp.htm
17. Erowid (2010) Erowid Experience Vaults: Piperazine Reports, http://www.erowid.org/chemicals/piperazines
18. Fantegrossi WE, Winger G, Woods JH, Woolverton WL, Coop A (2005) Reinforcing and discriminative stimulus effects of 1-benzylpiperazine and trifluoromethylphenylpiperazine in rhesus monkeys. Drug Alcohol Depend 77:161-168 (Pubitemid 40128194)
19. FDA (2008) U.S. Food and Drug Administration, http://www.fda.gov
20. Foltin RW, Fischman MW (1991) Assessment of abuse liability of stimulant drugs in humans: a methodological survey. Drug Alcohol Depend 28:3-48
21. Gee P, Gilbert M, Richardson S, Moore G, Paterson S, Graham P (2008) Toxicity from the recreational use of 1-benzylpiperazine. Clin Toxicol 46:802-807
22. Jan RK, Lin JC, Lee H, Sheridan JL, Kydd RR, Kirk IJ, Russell BR (2010) Determining the subjective effects of TFMPP in human males. Psychopharmacol Berl 211:347-353
23. Johnstone AC, Lea RA, Brennan KA, Schenk S, Kennedy MA, Fitzmaurice PS (2007) Benzylpiperazine: a drug of abuse? J Psychopharmacol 21:888-894
24. Kalant H (2001) The pharmacology and toxicology of 'ecstasy' (MDMA) and related drugs. CMAJ 165:917-928
25. Klodzinska A, Chojnacka-Wojcik E (1992) Hyperthermia induced by m-trifluoromethylphenylpiperazine (TFMPP) or m-chlorophenylpiperazine (m-CPP) in heat-adapted rats. Psychopharmacology 109:466-472
26. Lin JC, Bangs N, Lee H, Kydd RR, Russell BR (2009) Determining the subjective and physiological effects of BZP on human females. Psychopharmacol Berl 207:439-446
27. Magyar K, Fekete MI, Tekes K, Torok T (1986) The action of trelibet, a new antidepressive agent on [3 H]noradrenaline release from rabbit pulmonary artery. Eur J Pharmacol 130:219-227 (Pubitemid 17193206)
28. Martin WR, Sloan JW, Sapira JD, Jasinski DR (1971) Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man. Clin Pharmacol Ther 12:245-258
29. McCall RB, Patel BN, Harris LT (1987) Effects of serotonin1 and serotonin2 receptor agonists and antagonists on blood pressure, heart rate and sympathetic nerve activity. J Pharmacol Exp Ther 242:1152-1159 (Pubitemid 17156566)
30. McNair DM, Heuchert JWP, Shilony E (2003) Research with the Profile of Mood States (POMS) 1964-2002: A comprehensive bibliography. MHC Inc.: 7-8
31. Meririnne E, Kajos M, Kankaanpaa A, Seppala T (2006) Rewarding properties of 1-benzylpiperazine, a new drug of abuse, in rats. Basic Clin Pharmacol Toxicol 98:346-350
32. Millan MJ, Dekeyne A, Gobert A (1998) Serotonin (5-HT)2 C receptors inhibit dopamine (DA) and noradrenaline (NA) exact mechanism, but not 5-HT, release in the frontal cortex in vivo. Neuropharmacology 37:953-955
33. Miranda F, Orozco G, Velazquez-Martinez DN (2002) Full substitution of the discriminative cue of a 5-HT(1A/1B/2 C) agonist with the combined administration of a 5-HT(1B/2 C) and a 5-HT(1A) agonist. Behav Pharmacol 13:303-311 (Pubitemid 35026256)
34. Nissbrandt H, Waters N, Hjorth S (1992) The influence of serotoninergic drugs on dopaminergic neurotransmission in rat substantia nigra, striatum and limbic forebrain in vivo. Naunyn Schmiedebergs Arch Pharmacol 346:12-19
35. 1B receptor. Science 265:1875-1878
36. Sawynok J, Reid A (1992) Noradrenergic mediation of spinal antinociception by 5-hydroxytryptamine characterization of receptor subtypes. Eur J Pharmacol 223:49-56
37. Tancer M, Johanson C-E (2003) Reinforcing, subjective, and physiological effects of MDMA in humans: a comparison with d-amphetamine and mCPP. Drug Alcohol Depend 72:33-44 (Pubitemid 37255328)
38. Thompson I, Williams G, Caldwell B, Aldington S, Dickson S, Lucas N, McDowall J, Weatherall M, Robinson G, Beasley R (2010) Randomised double-blind, placebo-controlled trial of the effects of the 'party pills' BZP/TFMPP alone and in combination with alcohol. J Psychopharmacol 24:1299-1308
39. Trendelenburg U, Holdstock L, de Wit H (2001) Individual differences in responses to ethanol and d-amphetamine: a withinsubject study. Alcohol Clin Exp Res 25:540-548 (Pubitemid 32323421)
40. Volkow ND, Wang G-J, Ma Y, Fowler JS, Wong C, Jayne M, Telang F, Swanson JM (2006) Effects of expectation on the brain metabolic responses to methylphenidate and to its placebo in non-drug abusing subjects. Neuroimage 32:1782-1792 (Pubitemid 44332269)
41. White R, Standen O (1953) Piperazine in the treatment of threadworms in children; report on a clinical trial. BMJ 4:755-757
42. Wilkins C, Girling M, Sweetsur P, Huckle T, Huakau J (2006) Legal party pill use in New Zealand: Prevalence of use, availability, health harms and 'gateway effects' of benzylpiperazine (BZP) and triflourophenylmethylpiperazine (TFMPP). Centre for Social and Health Outcomes Research and Evaluation (SHORE), Massey University, Auckland